KRCA-0008 T2641
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
KRCA-0008 is an effective and specific ALK/Ack1 inhibitor (IC50: 12/4 nM); displays drug-like properties without hERG liability.
CAS nr:
1472795-20-2
Purity:
98%
Molecular Weight:
609,12
SMILES:
COc1c(Nc2ncc(Cl)c(Nc3c(OC)cc(cc3)N3CCN(CC3)C(=O)C)n2)ccc(c1)N1CCN(CC1)C(=O)C
Formula:
C30H37ClN8O4
Pathway:
Tyrosine Kinase/Adaptors,Angiogenesis,Tyrosine Kinase/Adaptors
Target:
ALK,ALK,ACK
